This study demonstrates that the FGF2, PDGFRA, PDGFRB, MMP2, and TIMP2 variants may contribute to treatment failure and poor prognosis in HNSCC. The gene discussed is PDGFRB; the disease is head and neck squamous cell carcinoma.